Search hospitals > Nevada > Las Vegas
HealthCare Partners Medical Group Oncology/Hematology-Tenaya
Claim this profileLas Vegas, Nevada 89128
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast Cancer
Conducts research for Relapse
140 reported clinical trials
1 medical researcher
Summary
HealthCare Partners Medical Group Oncology/Hematology-Tenaya is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Skin Cancer, Lung Cancer, Cancer, Breast Cancer, Relapse and other specialties. HealthCare Partners Medical Group Oncology/Hematology-Tenaya is involved with conducting 140 clinical trials across 321 conditions. There are 1 research doctors associated with this hospital, such as John A. Ellerton.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Clinical Trials running at HealthCare Partners Medical Group Oncology/Hematology-Tenaya
Lung Cancer
Bladder Carcinoma
Bladder Cancer
Testicular cancer
Skin Cancer
Non-Small Cell Lung Cancer
Kidney Cancer
Esophageal Adenocarcinoma
Cancer
Ovarian Tumors
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at HealthCare Partners Medical Group Oncology/Hematology-Tenaya?
HealthCare Partners Medical Group Oncology/Hematology-Tenaya is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Skin Cancer, Lung Cancer, Cancer, Breast Cancer, Relapse and other specialties. HealthCare Partners Medical Group Oncology/Hematology-Tenaya is involved with conducting 140 clinical trials across 321 conditions. There are 1 research doctors associated with this hospital, such as John A. Ellerton.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.